claim
The drug selpercatinib is approved to treat any cancer driven by a RET fusion, including medullary and papillary thyroid cancers, non-small cell lung cancer, colorectal cancer, and bile duct cancer.
Authors
Sources
- How does targeted therapy treat cancer? | UT MD Anderson www.mdanderson.org via serper
Referenced by nodes (1)
- non-small cell lung cancer concept